Condition: Non-Small Cell Lung Cancer · Sponsor: Tempus AI
GEMINI NSCLC Study is a non-interventional study that will be collecting clinical and molecular health information from patients with NSCLC who will receive longitudinal blood collection in addition to their standard of care therapy and disease surveillance with the goals of identifying the molecular evolution of lung cancer with standard of care therapy, and determining the utility of ctDNA dynamics to predict risk of recurrence and therapeutic outcomes.
This description comes directly from the study's public registry record.
GEMINI NSCLC · (833) 514-4187 · gemini-nsclc@tempus.com
Always discuss trial participation with your own doctor first.
| Alabama Oncology | Birmingham, Alabama, United States | Recruiting |
| Mercy Clinic Oncology - Fort Smith | Fort Smith, Arkansas, United States | Recruiting |
| MemorialCare | Fountain Valley, California, United States | Recruiting |
| Cancer and Blood Specialty Clinic | Los Alamitos, California, United States | Active Not Recruiting |
| UCLA | Los Angeles, California, United States | Recruiting |
| Eastern CT and Hematology and Oncology Associates | Norwich, Connecticut, United States | Recruiting |
| Clermont Oncology Center | Clermont, Florida, United States | Recruiting |
| Woodlands Medical Specialists | Pensacola, Florida, United States | Withdrawn |
| Morehouse School of Medicine (MSM) | Atlanta, Georgia, United States | Recruiting |
| Piedmont Healthcare | Atlanta, Georgia, United States | Recruiting |
| Hawaii Cancer Care | Honolulu, Hawaii, United States | Recruiting |
| Southern Illinois Hospital Services | Carterville, Illinois, United States | Recruiting |
+ 46 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05236114